Clinical Trial Update: Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating metformin hydrochloride in resectable pancreatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer | Phase 1 | Status: WITHDRAWN